Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Interaction of AD-2011 and AD-2012 in Healthy Volunteers
NCT03586037Phase 1Completed
- Sponsor
- Addpharma, Inc.
- Start
- Jun 2018
- Primary completion
- Aug 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of telmisartan, rosuvastatin and ezetimibe in hypertension (HTN) and hyperlipidemia (6 arms), sponsored by Addpharma, Inc. Primary endpoints: Peak Plasma Concentration and Area under the plasma concentration versus time curve. Started Jun 2018; status: completed.
02
Drugs
telmisartanrosuvastatinezetimibe
03
Conditions
hypertension (HTN)hyperlipidemia
Beyond the preview
Go deeper on NCT03586037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03586037.